Rule out compound heterozygous exonic/deep intronic ABCA4 variants in an MNGIE patient with Stargardt disease
American Journal of Medical Genetics Part A · 2024
DOI: 10.1002/ajmg.a.63404 ↗Kurz gefasst
Leserbrief in der Zeitschrift American Journal of Medical Genetics Part A, 2024. Verfasst von Josef Finsterer. Beteiligte Einrichtung: Neurology and Neurophysiology Center, Vienna, Austria. Hauptthemen laut MEDLINE: Macular Degeneration. Die Arbeit nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Neurology and Neurophysiology Center, Vienna, Austria.
ORCID-Profile: Josef Finsterer
Zitieren
APA
Finsterer, J. (2024). Rule out compound heterozygous exonic/deep intronic ABCA4 variants in an MNGIE patient with Stargardt disease. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.63404
Vancouver
Finsterer J. Rule out compound heterozygous exonic/deep intronic ABCA4 variants in an MNGIE patient with Stargardt disease. American Journal of Medical Genetics Part A. 2024. doi:10.1002/ajmg.a.63404
BibTeX
@article{Finsterer2024,
author = {Finsterer, Josef},
title = {Rule out compound heterozygous exonic/deep intronic ABCA4 variants in an MNGIE patient with Stargardt disease},
journal = {American Journal of Medical Genetics Part A},
year = {2024},
doi = {10.1002/ajmg.a.63404}
}
EUVIMED